AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36271753 — intervention group
Group type: EXPERIMENTAL
Intervention: office-based vergence/accommodative therapy
Number of subjects: 205
Study 33884674 — intervention group
Group type: EXPERIMENTAL
Intervention: High hemoglobin target (>12.5 g/dL)
Number of subjects: 153
Study 33884674 — intervention group
Group type: COMPARATOR
Intervention: Low hemoglobin target (<10.5 g/dL)
Number of subjects: 153
Study 33884674 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 1000 IU/day
Number of subjects: 153
Study 33884674 — intervention group
Group type: COMPARATOR
Intervention: Control (no vitamin D supplementation)
Number of subjects: 153
Study 35534590 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 M sodium chloride solution
Number of subjects: 74
Study 35534590 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 M sodium chloride solution
Number of subjects: 74
Study 33377565 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone application-based dietary self-management program
Number of subjects: 75
Study 33377565 — intervention group
Group type: COMPARATOR
Intervention: General program
Number of subjects: 75
Study 36164077 — intervention group
Group type: EXPERIMENTAL
Intervention: Loncastuximab tesirine (0.15 mg/kg) + rituximab (375 mg/m2) for 2 cycles, then Loncastuximab (0.075 mg/kg) + rituximab (375 mg/m2) for up to 6 additional cycles.
Number of subjects: 20
Study 36164077 — intervention group
Group type: COMPARATOR
Intervention: Control group: Rituximab-gemcitabine-oxaliplatin (R-GemOx) (not yet reported as this is part of the randomized phase).
Number of subjects: 20
Study 33024322 — intervention group
Group type: EXPERIMENTAL
Intervention: Early vitrectomy (2-4 days post-injury)
Number of subjects: 139
Study 33024322 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed vitrectomy (5-7 days post-injury)
Number of subjects: 139
Study 33024322 — intervention group
Group type: EXPERIMENTAL
Intervention: Late vitrectomy (8-14 days post-injury)
Number of subjects: 139
Study 33024322 — intervention group
Group type: EXPERIMENTAL
Intervention: Very late vitrectomy (>14 days post-injury)
Number of subjects: 139
Study 33131170 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser combined with L-GFs
Number of subjects: 45
Study 33131170 — intervention group
Group type: COMPARATOR
Intervention: Fractional CO2 laser combined with PRP
Number of subjects: 45
Study 36078667 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term psychoanalytic psychotherapy (STPP) with transference work
Number of subjects: 69
Study 36078667 — intervention group
Group type: COMPARATOR
Intervention: Short-term psychoanalytic psychotherapy (STPP) without transference work
Number of subjects: 69
Study 33038035 — intervention group
Group type: EXPERIMENTAL
Intervention: LSTM network for predicting fluid responsiveness
Number of subjects: 175
Study 33038035 — intervention group
Group type: COMPARATOR
Intervention: Point-of-care US experts using video review and manual measurement
Number of subjects: 175
Study 32681091 — intervention group
Group type: EXPERIMENTAL
Intervention: vorinostat, tamoxifen and pembrolizumab
Number of subjects: 34
Study 35192839 — intervention group
Group type: EXPERIMENTAL
Intervention: PROTECT III
Number of subjects: 504
Study 35769842 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200 mg daily for 10 days
Number of subjects: 82
Study 35769842 — intervention group
Group type: COMPARATOR
Intervention: Control group (colistin only)
Number of subjects: 82
Study 32949145 — intervention group
Group type: EXPERIMENTAL
Intervention: Health System-Based Dementia Care (HSDC)
Number of subjects: 2150
Study 32949145 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-Based Dementia Care (CBDC)
Number of subjects: 2150
Study 32949145 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 2150
Study 35986297 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture based on syndrome differentiation with donepezil (5 mg/day) for 12 weeks
Number of subjects: 184
Study 35986297 — intervention group
Group type: COMPARATOR
Intervention: Donepezil (5 mg/day)
Number of subjects: 184
Study 32162970 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) 100/62.5/25 μg
Number of subjects: 10355
Study 32162970 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone furoate/umeclidinium/vilanterol (FF/VI) 100/25 μg
Number of subjects: 10355
Study 32162970 — intervention group
Group type: COMPARATOR
Intervention: Umeclidinium/vilanterol (UMEC/VI) 62.5/25 μg
Number of subjects: 10355
Study 34774885 — intervention group
Group type: EXPERIMENTAL
Intervention: FDY-5301 (2.0 mg/kg)
Number of subjects: 120
Study 34774885 — intervention group
Group type: EXPERIMENTAL
Intervention: FDY-5301
Number of subjects: 120
Study 34774885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 34774885 — intervention group
Group type: EXPERIMENTAL
Intervention: FDY-5301 (0.5 mg/kg and 1.0 mg/kg)
Number of subjects: 120
Study 34776199 — intervention group
Group type: EXPERIMENTAL
Intervention: Mat Pilates (PG)
Number of subjects: 40
Study 34776199 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 40
Study 35923518 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord milking (UCM)
Number of subjects: 170
Study 35923518 — intervention group
Group type: COMPARATOR
Intervention: Control (cord clamped and cut without milking)
Number of subjects: 170
Study 35537896 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxilla-first approach (group I)
Number of subjects: 24
Study 35537896 — intervention group
Group type: COMPARATOR
Intervention: Mandible-first approach (group II)
Number of subjects: 24
Study 32057733 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyrax T‐RME
Number of subjects: 50
Study 32057733 — intervention group
Group type: EXPERIMENTAL
Intervention: Dresden B‐RME
Number of subjects: 50
Study 32057733 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 50
Study 34939609 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower limb high-intensity interval training (HIIT) for 23 minutes
Number of subjects: 2
Study 34939609 — intervention group
Group type: COMPARATOR
Intervention: Seated rest for 23 minutes
Number of subjects: 2
Study 32389434 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized decision aid intervention
Number of subjects: 184
Study 32389434 — intervention group
Group type: COMPARATOR
Intervention: CDC brochure about falls (Control)
Number of subjects: 184
Study 35049203 — intervention group
Group type: EXPERIMENTAL
Intervention: SUBAR-assisted gait training (n=15)
Number of subjects: 30
Study 35049203 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (control group, n=15)
Number of subjects: 30
Study 35243362 — intervention group
Group type: EXPERIMENTAL
Intervention: STAR care pathway plus usual care (n=242)
Number of subjects: 363
Study 35243362 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (n=121)
Number of subjects: 363
Study 34621380 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma patients
Number of subjects: 150
Study 34621380 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma patients with CC genotype
Number of subjects: 150
Study 34621380 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma patients with AA genotype
Number of subjects: 150
Study 34621380 — intervention group
Group type: EXPERIMENTAL
Intervention: TLR-4 rs4986791 polymorphism
Number of subjects: 150
Study 33526271 — intervention group
Group type: EXPERIMENTAL
Intervention: SURE RAB™ (inactivated cell culture derived rabies vaccine)
Number of subjects: 0
Study 33526271 — intervention group
Group type: COMPARATOR
Intervention: VERORAB (approved rabies vaccine)
Number of subjects: 0
Study 33526271 — intervention group
Group type: COMPARATOR
Intervention: Combined Group I + II (SURE RAB™ and VERORAB)
Number of subjects: 0
Study 34989778 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day regimen of postoperative prophylactic intravenous cephalosporin (cefazolin or cefuroxime)
Number of subjects: 604
Study 34989778 — intervention group
Group type: COMPARATOR
Intervention: 1-day regimen of postoperative prophylactic intravenous cephalosporin (cefazolin or cefuroxime)
Number of subjects: 604
Study 34086034 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid respiratory pathogen test results given to clinicians
Number of subjects: 931
Study 34086034 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical care (control group)
Number of subjects: 931
Study 34086034 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid respiratory pathogen test results known to clinicians (modified intention-to-treat analysis)
Number of subjects: 931
Study 33073449 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20 g day−1 for 5 days)
Number of subjects: 16
Study 33073449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 33073449 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine-Isotime (time matched to Baseline after creatine supplementation)
Number of subjects: 16
Study 33073449 — intervention group
Group type: COMPARATOR
Intervention: Placebo-Isotime (time matched to Baseline after placebo supplementation)
Number of subjects: 16
Study 36470312 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous Laser Ablation (EVLA)
Number of subjects: 161
Study 36470312 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound‐Guided‐Foam Sclerotherapy (UGFS)
Number of subjects: 161
Study 36470312 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (EVLA and UGFS)
Number of subjects: 161
Study 34411729 — intervention group
Group type: EXPERIMENTAL
Intervention: vNOTES
Number of subjects: 96
Study 34411729 — intervention group
Group type: COMPARATOR
Intervention: CL
Number of subjects: 96
Study 32748181 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery (LCS)
Number of subjects: 34
Study 32748181 — intervention group
Group type: COMPARATOR
Intervention: Conventional cataract surgery
Number of subjects: 34
Study 33765935 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive orthogeriatric care (CGC)
Number of subjects: 726
Study 33348935 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP intradermal injection
Number of subjects: 60
Study 33348935 — intervention group
Group type: EXPERIMENTAL
Intervention: FCL followed by topical PRP
Number of subjects: 60
Study 33348935 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling followed by topical PRP
Number of subjects: 60
Study 35781816 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg VE
Number of subjects: 240
Study 35781816 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg VE
Number of subjects: 240
Study 35781816 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg VE
Number of subjects: 240
Study 35781816 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/kg VE
Number of subjects: 240
Study 35781816 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/kg VE
Number of subjects: 240
Study 35781816 — intervention group
Group type: COMPARATOR
Intervention: Control group (basal diet)
Number of subjects: 240
Study 33980208 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple Decision Aid (DA)
Number of subjects: 285
Study 33980208 — intervention group
Group type: COMPARATOR
Intervention: Complex Decision Aid (DA)
Number of subjects: 285
Study 32298381 — intervention group
Group type: EXPERIMENTAL
Intervention: Siriraj Surgical ICU Nutrition Protocol
Number of subjects: 170
Study 32298381 — intervention group
Group type: COMPARATOR
Intervention: Control group (nutrition at discretion of attending physicians)
Number of subjects: 170
Study 33654316 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP-I 0.6% eye drops four times/daily for 20 days
Number of subjects: 59
Study 33654316 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronate-based tear substitutes four times/daily for 20 days
Number of subjects: 59
Study 32816021 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Fibrin Matrix (PRFM)
Number of subjects: 30
Study 32816021 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 30
Study 32816021 — intervention group
Group type: EXPERIMENTAL
Intervention: PRFM
Number of subjects: 30
Study 36128685 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced follow-up by stoma therapists with regular consultations after discharge
Number of subjects: 0
Study 36128685 — intervention group
Group type: COMPARATOR
Intervention: Standard follow-up
Number of subjects: 0
Study 35545816 — intervention group
Group type: EXPERIMENTAL
Intervention: ZFR00V multifocal intraocular lens (model ZFR00V)
Number of subjects: 150
Study 35545816 — intervention group
Group type: COMPARATOR
Intervention: TFNT00 trifocal intraocular lens (model TFNT00)
Number of subjects: 150
Study 35545816 — intervention group
Group type: COMPARATOR
Intervention: Both IOLs
Number of subjects: 150
Study 34156881 — intervention group
Group type: EXPERIMENTAL
Intervention: PET-driven group (doxorubicin, bleomycin, vinblastine, and dacarbazine regimen after two cycles of BEACOPPescalated)
Number of subjects: 569
Study 34156881 — intervention group
Group type: EXPERIMENTAL
Intervention: PET-driven group
Number of subjects: 569
Study 32246682 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diclofenac (50 mg twice daily)
Number of subjects: 32
Study 32246682 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal diclofenac patch (100 mg once daily)
Number of subjects: 32
Study 35799456 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced hydropolymer wound dressing with smartphone technology
Number of subjects: 200
Study 35799456 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 200
Study 34584010 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 109
Study 34584010 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive Ventilation (NIV)
Number of subjects: 109
Study 33038280 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin
Number of subjects: 114530
Study 33038280 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin
Number of subjects: 114530
Study 33038280 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble leptin receptor (sOB-R)
Number of subjects: 114530
Study 33038280 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasminogen activator inhibitor-1 (PAI-1)
Number of subjects: 114530
Study 32540842 — intervention group
Group type: EXPERIMENTAL
Intervention: One Drop with activity tracker
Number of subjects: 99
Study 32540842 — intervention group
Group type: COMPARATOR
Intervention: One Drop only
Number of subjects: 99
Study 33825577 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 936
Study 33825577 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular revascularization
Number of subjects: 936
Study 33825577 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular surgeons
Number of subjects: 936
Study 33825577 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical interventionalists
Number of subjects: 936
Study 33095849 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional citrate anticoagulation (n=300)
Number of subjects: 596
Study 33095849 — intervention group
Group type: COMPARATOR
Intervention: Systemic heparin anticoagulation (n=296)
Number of subjects: 596
Study 35849138 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigation to resources (NAV) facilitated by a Patient Navigator
Number of subjects: 110
Study 35849138 — intervention group
Group type: EXPERIMENTAL
Intervention: NAV + evidence-based nine-session diabetes self-management support (DSMS) program facilitated by a community health worker (CHW)
Number of subjects: 110
Study 35849138 — intervention group
Group type: COMPARATOR
Intervention: NAV
Number of subjects: 110
Study 35849138 — intervention group
Group type: COMPARATOR
Intervention: NAV + DSMS
Number of subjects: 110
Study 35142643 — intervention group
Group type: EXPERIMENTAL
Intervention: DRL_TZ (6 mg/kg, single intravenous infusion)
Number of subjects: 32
Study 35142643 — intervention group
Group type: COMPARATOR
Intervention: Herceptin® (6 mg/kg, single intravenous infusion)
Number of subjects: 32
Study 35142643 — intervention group
Group type: EXPERIMENTAL
Intervention: DRL_TZ
Number of subjects: 32
Study 35142643 — intervention group
Group type: COMPARATOR
Intervention: Herceptin®
Number of subjects: 32
Study 35195798 — intervention group
Group type: EXPERIMENTAL
Intervention: BIO‐A mesh supported colostomy (Mesh Group)
Number of subjects: 110
Study 35195798 — intervention group
Group type: COMPARATOR
Intervention: Conventional colostomy (Control Group)
Number of subjects: 110
Study 34444121 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal treatment (NSPT) with community health worker (CHW) strategy
Number of subjects: 68
Study 34444121 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical periodontal treatment (NSPT)
Number of subjects: 68
Study 32276676 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration (test)
Number of subjects: 28
Study 32276676 — intervention group
Group type: COMPARATOR
Intervention: No infiltration (control)
Number of subjects: 28
Study 35038479 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz)
Number of subjects: 37
Study 35038479 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 37
Study 35038479 — intervention group
Group type: COMPARATOR
Intervention: Neurostimulation alone without cognitive restructuring
Number of subjects: 37
Study 34708471 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics containing Lactobacillus acidophilus and Lactobacillus rhamnosus
Number of subjects: 40
Study 34708471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32272253 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopic guided spinal biopsy
Number of subjects: 60
Study 32272253 — intervention group
Group type: COMPARATOR
Intervention: CT guided spinal biopsy
Number of subjects: 60
Study 35901118 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosocial behavior
Number of subjects: 1234
Study 35901118 — intervention group
Group type: COMPARATOR
Intervention: Self-focused behavior
Number of subjects: 1234
Study 35901118 — intervention group
Group type: COMPARATOR
Intervention: Neutral behavior
Number of subjects: 1234
Study 33383580 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidose metronidazole for male partners (2×/day for 7 days)
Number of subjects: 214
Study 33383580 — intervention group
Group type: COMPARATOR
Intervention: Placebo for male partners
Number of subjects: 214
Study 33383580 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to multidose metronidazole by male partners
Number of subjects: 214
Study 36151343 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP) with oral antibiotics (OA) using Alfa Normix®
Number of subjects: 0
Study 36151343 — intervention group
Group type: COMPARATOR
Intervention: Mechanical bowel preparation (MBP) alone
Number of subjects: 0
Study 33137675 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 77
Study 33137675 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 77
Study 33137675 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdebrider-assisted inferior turbinoplasty (MAIT)
Number of subjects: 77
Study 34231290 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized outpatient cardiac rehabilitation combined with treadmill power walking (intervention group)
Number of subjects: 24
Study 34231290 — intervention group
Group type: COMPARATOR
Intervention: Standardized outpatient cardiac rehabilitation alone (control group)
Number of subjects: 24
Study 33017172 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based resilience training (MBRT)
Number of subjects: 28
Study 34942066 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2
Number of subjects: 219842
Study 34942066 — intervention group
Group type: COMPARATOR
Intervention: mRNA-1273
Number of subjects: 219842
Study 33975053 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning Together intervention, a school-based intervention including restorative practice
Number of subjects: 0
Study 33975053 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning Together intervention
Number of subjects: 0
Study 33583304 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Cuff Manager (SCM)
Number of subjects: 60
Study 33583304 — intervention group
Group type: COMPARATOR
Intervention: Manual Measurement Approach (MMA)
Number of subjects: 60
Study 32502588 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapinarof cream 0.5%
Number of subjects: 247
Study 32502588 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapinarof cream 1%
Number of subjects: 247
Study 32502588 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 247
Study 32502588 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapinarof cream 0.5% once daily
Number of subjects: 247
Study 32502588 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapinarof cream 0.5% twice daily
Number of subjects: 247
Study 32502588 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapinarof cream 1% twice daily
Number of subjects: 247
Study 32502588 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapinarof cream 0.5% once or twice daily
Number of subjects: 247
Study 32502588 — intervention group
Group type: EXPERIMENTAL
Intervention: All tapinarof groups
Number of subjects: 247
Study 34216454 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1% with epinephrine (40 ml)
Number of subjects: 20
Study 34216454 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 2% with epinephrine (20 ml)
Number of subjects: 20
Study 33742536 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with social roles
Number of subjects: 209
Study 33742536 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety symptoms
Number of subjects: 209
Study 33742536 — intervention group
Group type: EXPERIMENTAL
Intervention: Manic symptoms
Number of subjects: 209
Study 33742536 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion-focused positive rumination
Number of subjects: 209
Study 36307989 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical gentamicin cream delivered via the platform wound device (PWD)
Number of subjects: 0
Study 36307989 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC) dressings
Number of subjects: 0
Study 36266111 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile emergency medical dispatch tool
Number of subjects: 10